An online scientific seminar series focused on motor neurone disease (MND) Research. Hear from national experts and emerging leaders in MND research including the latest clinical trials, drug developments, pre-clinical models, discovery research and collaborative platforms. Learn, connect and share with the Australian MND research community.
For enquiries related to the seminar series, please contact: Dr Sarah Bennett
In this presentation, Professor Woodruff will provide an overview of key immune targets in MND investigated by his laboratory. He will present evidence linking myeloid cells, inflammatory biomarkers and clinical phenotypes in individuals living with MND. The talk will also explore the challenges of clinically targeting innate immune pathways for neurodegenerative disease and propose strategies to overcome these setbacks to advance therapeutic development.
Professor Trent Woodruff is an NHMRC Investigator Fellow at The University of Queensland, with over 20 years of experience in developing drug therapies for motor neuron disease (MND). He leads a research team investigating the role of innate immunity in neurodegeneration, particularly how immune cells drive pathogenic inflammation. His work has pioneered the development of novel complement and innate immune-targeted therapies, with a focus on translating these discoveries into clinical treatments. As an active collaborator, Professor Woodruff has published over 240 research papers in leading journals including Nature, Cell, Science, PNAS, and The Lancet, and holds several patents for therapeutic innovations targeting neuroinflammatory pathways in brain disease.
Dr Anne Hogden, Feb2024